Lawyers Weekly USA reported on April 18th about the updates warnings the FDA is requiring for the birth control pills Yaz and Yasmin. The article reports that some studies have shown a threefold risk of developing blood clots while taking Yaz. Partially as a result of those studies, the FDA now states that “[h]ealth care professionals should consider the risks and benefits of drospirenone-containing birth control pills and a woman’s risk for developing a blood clot before prescribing these drugs.” Drospirenone is one of the ingredients in Yaz, and is a synthetic version of the hormone progesterone.
The article also points out that Bayer has already settled 70 out of approximately 11,300 Yaz lawsuits currently pending.
Comments